Recently, a global exercise resulted in the harmonisation of the definition and designation of these infants as Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CRMS/CFSPID) [30,31]. This evidence concerns the gene CFTR and metabolic syndrome.